Editor, Gazette-Journal:

Do these horror stories chill your sensibilities?

“Eli Lilly charges more than $13,000 a month for Cyramza … Novartis’s Zykadia costs almost $14,000 a month. Amgen’s Blincyto…will cost $64,000 a month,” says a New York Times Op-Ed in January 2015.

Business Insider writes, “From 2008 through 2014, average prices for the most widely used brand-name drugs jumped 128 percent, according to prescription-benefit manager Express Scripts Holding Co.”

Congressman Wittman’s constituents were already paying more. In February 2014 PBS NewsHour cited, “Prices in the U.S. for brand-name patented drugs are 50 to 60 percent higher than in France and twice as high as in the United Kingdom or Australia.”

Congressman Wittman, should drug companies be permitted to buy older generic drugs and then raise prices? Business Insider cites, “Turing Pharmaceuticals raised the price of Daraprim” (a 62-year-...